Filing Details

Accession Number:
0001209191-11-041982
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-08-02 13:00:00
Reporting Period:
2011-08-01
Filing Date:
2011-08-02
Accepted Time:
2011-08-02 16:18:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816284 Celgene Corp CELG Pharmaceutical Preparations (2834) 222711928
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1405288 A Jacqualyn Fouse C/O Celgene Corporation
86 Morris Avenue
Summit NJ 07901
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-08-01 2,000 $59.47 5,085 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2011-08-01 11,250 $0.00 11,250 $58.47
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,250 2021-08-01 No 4 A Direct
Footnotes
  1. Option is immediately exercisable and will vest in four equal annual installments commencing on August 1, 2012.
  2. The option was issued pursuant to the Company's 2008 Stock Incentive Plan.